Incara Pharmaceuticals

NCT00003073

Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid Tumors

NCT00653419

Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting Conditions

NCT00652730

Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting and Fed Conditions

NCT01375244

Comparative Bioavailability Study of Lisinopril Tablets, 10 mg

NCT00652704

Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting and Fed Conditions

NCT01380431

A Comparative Bioavailability Study of Lisinopril Tablets, 40 mg - Effect of Food Study

NCT00653380

Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting Conditions

NCT01380496

Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fed Conditions

NCT01380483

Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fasting Conditions

NCT00653549

Bioavailability Study of Torsemide Tablets Under Fasting Conditions

NCT00654043

Bioavailability Study of Torsemide Tablets Under Fed Conditions

NCT00652873

Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fed Conditions

NCT00653055

Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fasting Conditions

NCT00652821

Bioavailability Study of Tramadol/APAP Tablets Under Fed Conditions

NCT00653315

Bioavailability Study of Tramadol/APAP Tablets Under Fasting Conditions

NCT00728832

A Pharmacokinetic (PK) Study of Extended-Release Epidural Morphine in Upper Abdominal Surgery

NCT00983996

Fasting Study of Alendronate Sodium Tablets (10 mg) and Fosamax Tablets (10 mg)

NCT00649129

Fasting Study of Oxybutynin Chloride ER Tablets 10 mg and Ditropan XL® Tablets 10 mg

NCT00649727

Fed Study of Oxybutynin Chloride Extended-release Tablets 10 mg and Ditropan XL® Tablets 10 mg

NCT00650013

Fed Study of Midodrine HCl Tablets 5 mg and ProAmatine® Tablets 5 mg

NCT01012934

Fasting Study of Alendronate Sodium Tablets (70 mg) and Fosamax Tablets (70 mg)

NCT01018342

Fed Study of Mylan Nitrofurantoin Monohydrate/Macrocrystals Capsules 100 mg and Macrobid® Capsules 100 mg

NCT00650364

Fasting Study of Midodrine HCl Tablets 5 mg and ProAmatine® Tablets 5 mg

NCT00653458

Bioavailability Study of Ondansetron Orally Disintegrating Tablets Under Fed Conditions

NCT00654277

Bioavailability Study of Ondansetron Orally Disintegrating Tablets Under Fasting Conditions

NCT01380509

Bioavailability Study of Metronidazole Capsules Under Fasting Conditions

NCT01380522

Bioavailability Study of Metronidazole Capsules Under Fed Conditions

NCT00650286

Food Study of Modafinil Tablets 200 mg to Provigil® Tablets 200 mg

NCT00648440

Food Study of Midodrine HCl Tablets 5 mg and ProAmatine® Tablets 5 mg

NCT00648492

Food Study Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR 500 mg

NCT00649259

Food Study of Oxybutynin Chloride ER Tablets 10 mg and Ditropan XL® Tablets 10 mg

NCT00649285

Food Study of Nitrofurantoin Monohydrate/Macrocrystals Capsules 100 mg and Macrobid® Capsules 100 mg

NCT00650000

Fasting Study of Modafinil Tablets 200 mg and Provigil® Tablets 200 mg

NCT00650312

Fasting Study of Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR Tablets 500 mg

NCT00649597

Fasting Study of Benazepril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Lotensin HCT® Tablets 20 mg/25 mg

NCT00649857

Food Study of Cetirizine HCl Tablets 10 mg and Zyrtec® 10 mg

NCT00650065

Fasting Study of Cetirizine HCl Tablets 10 mg and Zyrtec® Tablets 10 mg

NCT00650325

Study of Sertraline Hydrochloride Tablets 100 mg and Zoloft® Tablets 100 mg

NCT00648271

Fed Study of Metoprolol Tartrate Tablets 25 mg and Lopressor® 50 mg

NCT00648843

Food Study of Oxybutynin Chloride Extended-release Tablets 5 mg and Ditropan XL® Tablets 5 mg

NCT00648856

Food Study of Sertraline Hydrochloride Tablets 100 mg and Zoloft® Tablets 100 mg

NCT00649038

Fed Study of Benazepril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Lotensin HCT® Tablets 20 mg/25 mg

NCT00649051

Fasting Study of Metolazone Tablets 2.5 mg and Zaroloxyn® Tablets 2.5 mg

NCT00649103

Fasting Study of Quinapril Hydrochloride Tablets 40 mg and Accupril® Tablets 40 mg

NCT00649116

Fed Study of Metoprolol Tartrate Tablets 100 mg and Lopressor® 100 mg

NCT00649649

Food Study of Quinapril Hydrochloride Tablets 40 mg and Accupril® Tablets 40 mg

NCT00650481

Fasting Study of Oxybutynin Chloride Extended-release Tablets 5 mg and Ditropan XL® Tablets 5 mg

NCT00648024

Fasting Study of Anagrelide Hydrochloride Capsules 1 mg to Agrylin® Capsules 1 mg

NCT00648557

Fasting Study of Levothyroxine Sodium Tablets 200 mg to Synthroid Tablets 200 mg

NCT00648765

Fed Study of Anagrelide Hydrochloride Capsules 1 mg to Agrylin® Capsules 1 mg

NCT00648778

Fasting Study of Loxapine Succinate Capsules 25 mg and Loxitane® Capsules 25 mg

NCT00649233

Food Study of Metoprolol Tartrate/Hydrochlorothiazide Tablets 100/50 mg to Lopressor HCT® Tablets 100/50 mg

NCT00649688

Fasting Study of Metoprolol Tartrate/Hydrochlorothiazide Tablets 100/50 mg and Lopressor HCT® Tablets 100/50 mg

NCT00650442

Evaluation of Adhesion Quality and Irritation of an Alternate Second Generation Estradiol Transdermal System

NCT00649558

Fasting Study of Pioglitazone HCl Tablets 45 mg and Actos® Tablets 45 mg

NCT00648128

Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Fed State

NCT00649012

Food Study of Pioglitazone HCl Tablets 45 mg to Actos® Tablets 45 mg

NCT00647855

Fasting Study of Levothyroxine Sodium Tablets 300 μg to Synthroid® Tablets 300 μg

NCT00647972

Fasting Study of Olanzapine Tablets 20 mg and Zyprexa® Tablets 20 mg

NCT00648349

Fasting Study of Rabeprazole Sodium Delayed-Release Tablets 20 mg to Aciphex® Delayed-Release Tablets 20 mg

NCT00649493

Fed Study of Rabeprazole Sodium Tablets 20 mg and Aciphex® Tablets 20 mg

NCT00647777

Food Study of Olanzapine Tablets 5 mg and Zyprexa® Tablets 5 mg

NCT00648921

Fasting Study of Olanzapine Tablets 5 mg and Zyprexa® Tablets 5 mg

NCT00650221

Fasting Bioequivalence Study of Pravastatin Sodium 80 mg Tablets Versus Pravachol® 80 mg Tablets In Normal Healthy Subjects

NCT00652665

Bioavailability Study of Leflunomide Tablets Under Fasting Conditions

NCT00648544

Fed, Bioequivalence Study of Pravastatin Sodium 80 mg Tablets Versus Pravachol® 80 mg Tablets In Subjects

NCT00648583

Food Study of Ondansetron Tablets 24 mg and Zofran® Tablets 24 mg

NCT00648960

Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Fasting State

NCT00649532

Fasting Study of Ondansetron Tablets 24 mg and Zofran® Tablets 24 mg

NCT00648011

Food Study of Quinapril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Accuretic™ Tablets 20 mg/25 mg

NCT00649194

Food Study of Rabeprazole Sodium Delayed-Release Tablets 20 mg to Aciphex® Tablets 20 mg

NCT00649441

Fasting Study of Quinapril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Accuretic™ Tablets 20 mg/25 mg

NCT00649896

Evaluation of Adhesion Quality of a New Formulation of the Mylan Estradiol Transdermal System 0.025 mg/Day and Climara® Transdermal System 0.025 mg/Day

NCT00649506

Food Study of Nitrofurantoin Macrocrystals 100 mg Capsules and Macrodantin® 100 mg

NCT00647738

Comparative Bioavailability Study of Baclofen 20 mg Tablets in Healthy Male Volunteers / Fasting State

NCT00649181

Fasting Study of Metolazone Tablets 5 mg and Zaroloxyn® Tablets 5 mg

NCT00649376

Fasting Study of Fexofenadine Tablets 180 mg and Allegra® Tablets 180 mg

NCT00659074

Bioavailability Study of Ondansetron 24 mg Orally Disintegrating Tablets Under Fasting Conditions

NCT00647985

Food Study of Fexofenadine Tablets 180 mg and Allegra® Tablets 180 mg

NCT00648336

Fasting Study of Mercaptopurine 50 mg and Purinethol® Tablets 50 mg

NCT00650052

Fasting Study of Zonisamide Capsules 100 mg and Zonegran® Capsules 100 mg

NCT00659685

Bioavailability Study of Ondansetron 16 mg Orally Disintegrating Tablets Under Fasting Conditions

NCT00648518

Fasting Study of Metformin Hydrochloride ER Tablets 750 mg and Glucophage® XR Tablets 750 mg

NCT00649350

Food Study Metformin Hydrochloride ER Tablets 750 mg and Glucophage XR 750 mg

NCT00649714

Fed Study of Zonisamide Capsules 100 mg and Zonegran® Capsules 100 mg

NCT00653003

Bioavailability Study of Leflunomide Tablets Under Fed Conditions

NCT00647647

Fasting Study of Terbinafine Hydrochloride Tablets 250 mg and Lamisil® Tablets 250 mg

NCT00648713

Fed Study of Terbinafine Hydrochloride Tablets 250 mg and Lamisil® 250 mg

NCT00649948

Food BE Study Metformin Hydrochloride ER Tablets 500 mg and Glucophage XR 500 mg

NCT00650195

Fasting Study of Metolazone Tablets 10 mg and Zaroloxyn® Tablets 10 mg

NCT00650234

Fasting BE Study of Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR Tablets 500 mg

NCT00652639

Bioavailability Study of Clonazepam Tablets Under Fasting Conditions

NCT00648388

Fasting Study of Cilostazol Tablets 100 mg and Pletal® Tablets 100 mg

NCT00650416

Fasting Study of Carvedilol Tablets 12.5 mg to Coreg® Tablets 12.5 mg

NCT00652912

Bioavailability Study of Clonazepam ODT Under Fasting Conditions

NCT00648622

Fed Study of Carvedilol Tablets 12.5 mg to Coreg® Tablets 12.5 mg

NCT00648531

Fasting Study of Balsalazide Disodium Capsules 750 mg and Colazal® Capsules 750 mg

NCT00648830

Comparative Bioavailability Study of Clarithromycin 250 mg Tablets

NCT00649402

Fed Study of Amlodipine and Benazepril HCl Capsules 10 mg/20 mg to Lotrel® Capsules 10 mg/20 mg

NCT00649519

Fasting Study of Amlodipine and Benazepril HCl Capsules 10 mg/20 mg to Lotrel® Capsules 10 mg/20 mg

NCT00650208

Fasting Study of Lamotrigine Tablets 25 mg to Lamictal® Tablets 25 mg

NCT00652795

Bioequivalence Study Doxycycline Tablets and Monodox Capsules Under Fasting Conditions

NCT00647634

Fasting Study of Alprazolam Extended-Release Tablets 3 mg to Xanax XR® Tablets 3 mg

NCT00647751

Food Study of Lamotrigine Tablets 25 mg to Lamictal® Tablets 25 mg

NCT00648570

Fasting Study of Escitalopram Oxalate Tablets 20 mg and Lexapro® Tablets 20 mg

NCT00649077

Fasting Study of Meloxicam Tablets 15 mg and Mobic® Tablets 15 mg

NCT00649675

Food Study of Meloxicam Tablets 15 mg and Mobic® Tablets 15 mg

NCT00650299

Fed Study of Alprazolam Extended-release Tablets 3 mg to Xanax XR® Tablets 3 mg

NCT00648661

Food Study of Escitalopram Oxalate Tablets 20 mg to Lexapro® Tablets 20 mg

NCT00648791

Fasting Study of Finasteride Tablets 5 mg and Proscar Tablets 5 mg

NCT00650377

Fed Study of Finasteride Tablets 5 mg and Proscar® Tablets 5 mg

NCT00653393

Bioavailability Study of Tranylcypromine 10mg Tablets Under Fasting Conditions

NCT00648362

Fasting Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mg

NCT00648466

Fasting Study of Sumatriptan Succinate Tablets 100 mg to Imitrex® Tablets 100 mg

NCT00650247

Food Study of Sumatriptan Succinate Tablets 100 mg to Imitrex® Tablets 100 mg

NCT00650533

Food Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mg

NCT00647712

Fasting Study of Divalproex Sodium Extended-Release Tablets 500 mg to Depakote ER® Tablets 500 mg

NCT00648076

Food Study of Divalproex Sodium Extended-Release Tablets 500 mg to Depakote ER® Tablets 500 mg

NCT00648947

Fasting Study of Clopidogrel Bisulfate Tablets 75 mg to Plavix® Tablets 75 mg

NCT00649818

Fasting Study of Lorazepam Tablets 2 mg and Ativan Tablets 2 mg

NCT00650169

Food Study of Clopidogrel Bisulfate Tablets 75 mg to Plavix® Tablets 75 mg

NCT00647894

Fasting Study of Alprazolam Extended-Release Tablets 1 mg to Xanax XR Tablets 1 mg

NCT00652886

Bioavailability Study of Oxandrolone Tablets Under Fasting Conditions

NCT00647881

Food Study of Paroxetine Hydrochloride Controlled-Release Tablets 25 mg to Paxil CR™ Tablets 25 mg

NCT00648427

Fasting Study of Paroxetine Hydrochloride Controlled-Release Tablets 25 mg to Paxil CR™ Tablets 25 mg

NCT00650273

Fasting Study of Azithromycin Tablets 600 mg to Zithromax® Tablets 600 mg

NCT00649870

Food Study of Valacyclovir Hydrochloride Tablets 1000 mg to Valtrex® Tablets 1000 mg

NCT00649935

Fed Study of Azithromycin Tablets 600 mg to Zithromax® Tablets 600 mg

NCT00649974

Fasting Study of Valacyclovir Hydrochloride Tablets 1000 mg and Valtrex® Tablets 1000 mg

NCT00648505

Food Study of Glipizide and Metformin HCl Tablets 5 mg/500 mg to Metaglip® Tablets 5 mg/500 mg

NCT00649454

Fasting Study of Glipizide and Metformin HCl Tablets 5 mg/500 mg to Metaglip® Tablets 5 mg/500 mg

NCT00648180

Food Study of Doxycycline Monohydrate Tablets 100 mg and Adoxa Tablets 100 mg

NCT00648804

Food Study of Ondansetron Orally Disintegrating Tablets 8 mg to Zofran ODT® Tablets 8 mg

NCT00649363

Fasting Study of Ondansetron Orally Disintegrating Tablets 8 mg to Zofran ODT® Tablets 8 mg

NCT00649571

Fasting Study of Doxycycline Monohydrate Tablets 100 mg and Adoxa Tablets 100 mg

NCT00648700

Fasting Study of Levothyroxine Sodium Tablets 300 μg to Levothroid® Tablets 300 μg

NCT00650494

Fed Study of Valacyclovir Hydrochloride Tablets 1000 mg and Valtrex® Tablets 1000 mg

NCT00647608

Food Study of Propranolol Hydrochloride Extended-Release Capsules 160 mg and Inderal® LA Capsules 160 mg

NCT00647816

Fasting Study of Propranolol Hydrochloride Extended-Release Capsules 160 mg and Inderal® LA Capsules 160 mg

NCT00649779

Fasting Study of Albuterol Sulfate Extended-Release Tablets 8 mg and VoSpire® ER Tablets 8 mg

NCT00649987

Fed Study of Albuterol Sulfate Extended-Release Tablets 8 mg and VoSpire® ER Tablets 8 mg

NCT00652600

Bioavailability Study of Propranolol Under Fed Conditions

NCT00647621

Steady-State Study of Extended Phenytoin Sodium Capsules 100 mg and Dilantin® Kapseals® 100 mg

NCT00649662

Fasting Study of Ciprofloxacin Extended-Release Tablets 1000 mg and Cipro® XR Tablets 1000 mg

NCT00650351

Food Study of Ciprofloxacin Extended-Release Tablets 1000 mg and Cipro® XR Tablets 1000 mg

NCT00647842

Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System

NCT00648063

Fasting Study of Letrozole Tablets 2.5 mg and Femara® Tablets 2.5 mg

NCT00648154

Food Study of Letrozole Tablets 2.5 mg and Femara® Tablets 2.5 mg

NCT00648934

Fed Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg

NCT00649155

Fasting Study of Ciprofloxacin Extended-Release Tablets 500 mg and Cipro® XR Tablets 500 mg

NCT00649467

Applesauce Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg

NCT00649740

Fasting Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg

NCT00648219

Fed Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mg

NCT00649623

Fasting Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mg

NCT00647673

Fasting Study of Verapamil HCl Extended-Release Capsules 300 mg and Verelan® PM Extended-Release Capsules 300 mg

NCT00648401

Food Study of Verapamil HCl Extended-Release Capsules 300 mg and Verelan® PM Extended-Release Capsules 300 mg

NCT00649272

Fasting Study of Oxybutynin Chloride Extended-Release Tablets 15 mg and Ditropan XL® Tablets 15 mg

NCT00649805

Fasting Applesauce Study of Verapamil HCl Extended-Release Capsules 300 mg and Verelan® PM Extended-Release Capsules 300 mg

NCT01380457

Bioavailability Study of Dronabinol Capsules 10 mg Under Fasting Conditions

NCT00649636

Fasting Study of Fluoxetine Capsules 40 mg and Prozac Pulvules 40 mg

NCT00647959

Fasting Study of Doxycycline Monohydrate Tablets 150 mg and Adoxa Tablets 150 mg

NCT00648050

Fasting Study of Verapamil HCl Extended-Release Capsules 300 mg to Verelan® PM Extended-Release Capsules 300 mg

NCT00637403

Effect of Renal Impairment on the Pharmacokinetics, and Safety of Megestrol Acetate Concentrated Suspension

NCT00647686

Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System With Askina Derm Overlay

NCT00647660

Fasting Study of Nadolol/Bendroflumethiazide Tablets 80 mg/5 mg and Corzide® Tablets 80 mg/5 mg

NCT00648297

Fed Study of Nadolol/Bendroflumethiazide Tablets 80 mg/5 mg and Corzide® Tablets 80 mg/5 mg

NCT00648414

Study of the Effect of Clinical Procedures on Drug Delivery of Mylan Fentanyl Transdermal System 25 µg/hr and Duragesic® 25 µg/hr

NCT00650117

Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System

NCT01019590

Fed Study of Olmesartan Medoxomil and Hydrochlorothiazide Tablets 40 mg/25 mg and Benicar HCT® Tablets 40 mg/25 mg

NCT01020214

Fasting Study of Olmesartan Medoxomil and Hydrochlorothiazide Tablets 40 mg/25 mg and Benicar HCT® Tablets 40 mg/25 mg

NCT00650403

Food Study of Paroxetine Hydrochloride Tablets 40 mg and Paxil® Tablets 40 mg

NCT00649480

Fed Study of Balsalazide Disodium Capsules 750 mg and Colazal® Capsules 750 mg

NCT00730197

Fasting Bioequivalence Study of Nisoldipine Extended-Release Tablets 40 mg

NCT00648882

Fasting Study of Levothyroxine Sodium Tablets 300 mcg to Synthroid® Tablets 300 mcg

NCT00979537

Single-Dose Fed Bioequivalence Study of Nisoldipine Extended-Release Tablets (40 mg; Mylan) and Sular® Extended-Release Tablets (40 mg; First Horizon) in Healthy Volunteers

NCT00649168

Fed Study of (Parlodel®) Bromocriptine Mesylate Capsules 5 mg

NCT00650520

Fed Study of (Parlodel®) 2.5 mg Bromocriptine Mesylate Tablets

NCT00485667

Phase 1 Thorough QT Study in Young Healthy Volunteers

NCT00985660

Bioequivalence Study of Nisoldipine Extended-Release Tablets, 30 mg

NCT01183676

Fed Bioequivalence Study of Divalproex Sodium Delayed-Release Tablets, 500 mg

NCT01184391

Bioequivalence Study of Divalproex Sodium Delayed-Release Tablets, 500 mg

NCT00978055

Fasting Study of Liothyronine Sodium Tablets (50 Mcg) to Cytomel® Tablets (50 Mcg)

NCT00806806

Evaluate the Onset of Action of SKY0402 Following Local Infiltration in Healthy Volunteers

NCT00812305

Hepatic Impairment Study: Pharmacokinetics in Healthy and Hepatically Impaired Subjects

NCT00932256

Clinical Trial of STAHIST in Seasonal Allergic Rhinitis Patients

NCT01008397

Study of AHIST in Seasonal Allergic Rhinitis Patients

NCT01349140

EXPAREL Dose-Response for Single-Injection Femoral Nerve Blocks

NCT02594761

Phase 1 Study of Trastuzumab Administered as a Single Intravenous Infusion

NCT02109185

A Comparison of Mometasone Nasal Spray, Nasonex Nasal Spray, Nasonex Nasal Spray Suspension, & Placebo for Treatment of Seasonal Allergies for Safety, Efficacy, & Superiority in 1520 Male & Female Volunteers

NCT01966328

A Safety and Efficacy Assessment of Resolvine for Treatment of Vitreomacular Attachment

NCT02210247

Safety and Pharmacokinetics Study of Redosing EXPAREL in Healthy Volunteers

NCT02519335

Use of the Cardioprotectant Dexrazoxane During Congenital Heart Surgery: Proposal for Pilot Investigation

NCT02985762

PK Study of EXPAREL in Subjects Undergoing Open Spinal Fusion or Reconstructive Surgery

NCT03485014

Study in Pediatric Subjects Evaluating Pharmacokinetics and Safety of EXPAREL

NCT03428984

Study in Adult Subjects Undergoing Posterolateral Thoracotomy

NCT03880487

A Single and Multiple Ascending Dose Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of KP-1199

NCT04002089

Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety, of EXPAREL Administered as Sciatic Nerve Block (In Popliteal Fossa), for Postsurgical Analgesia in Subjects Undergoing Bunionectomy

NCT04293809

Study to Evaluate the Pharmacokinetics and Safety of EXPAREL Administered as a Pectoral Plane Block in Women Undergoing Breast Augmentation

NCT04119687

Study to Evaluate the Safety and Tolerability of FX201 in Patients with Osteoarthritis of the Knee

NCT04173611

Evaluation of Safety, Pharmacokinetics and Pharmacodynamics of EXPAREL® Administered Via a Single Intrathecal Injection to Healthy Volunteers

NCT04261049

Effect of Zilretta Injection

NCT04826328

Study to Evaluate the Safety and Tolerability of FX301 in Patients Undergoing Bunionectomy

NCT05222802

A Study to Evaluate ERAS-801 in Patients With Recurrent Glioblastoma (THUNDERBBOLT-1)

NCT05456490

Phase 1, Dose Escalation Study to Evaluate of Safety, Pharmacokinetics and Pharmacodynamics of Liposomal Bupivacaine 13.3 Administered Via a Single Intrathecal Injection to Healthy Volunteers

NCT06271265

Study to Evaluate the Pharmacokinetics and Safety of EXPAREL for Postoperative Analgesia in Subjects Undergoing Cardiac Surgery